NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
121 Uppsala |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 68 | 0.5% | 11 | 0.1% | 1 | 0.0% | 3 | 0.0% | 1 | 0.0% | . | . | . | . | 14148 | 99.4% | 14232 | 100.0% |
ASCUS | 27 | 6.1% | 56 | 12.6% | 8 | 1.8% | 33 | 7.4% | 2 | 0.4% | 1 | 0.2% | 2 | 0.4% | 316 | 71.0% | 445 | 100.0% |
CIN1 | 41 | 6.6% | 113 | 18.2% | 19 | 3.1% | 108 | 17.4% | 2 | 0.3% | 1 | 0.2% | 9 | 1.5% | 327 | 52.7% | 620 | 100.0% |
Atypical glandular cells/AGC | 5 | 45.5% | 1 | 9.1% | 1 | 9.1% | 2 | 18.2% | . | . | 2 | 18.2% | . | . | . | . | 11 | 100.0% |
Unclear atypia | 2 | 28.6% | 3 | 42.9% | . | . | 2 | 28.6% | . | . | . | . | . | . | . | . | 7 | 100.0% |
ASC-H | 2 | 14.3% | 4 | 28.6% | . | . | 6 | 42.9% | 1 | 7.1% | 1 | 7.1% | . | . | . | . | 14 | 100.0% |
CIN2 | 6 | 9.5% | 11 | 17.5% | 10 | 15.9% | 29 | 46.0% | . | . | 1 | 1.6% | . | . | 6 | 9.5% | 63 | 100.0% |
CIN3 | 1 | 1.1% | 10 | 10.9% | 3 | 3.3% | 65 | 70.7% | 2 | 2.2% | 8 | 8.7% | . | . | 3 | 3.3% | 92 | 100.0% |
Adenocarcinoma | 1 | 100.0% | . | . | . | . | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% |
Squamous cell cancer | 1 | 25.0% | . | . | . | . | . | . | . | . | 2 | 50.0% | . | . | 1 | 25.0% | 4 | 100.0% |
Total | 154 | 1.0% | 209 | 1.3% | 42 | 0.3% | 248 | 1.6% | 8 | 0.1% | 16 | 0.1% | 11 | 0.1% | 14801 | 95.6% | 15489 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80009, M80703, M81401, M81403, M85603 |